Gosia Weis
Family · Park Ridge, ILNPI 1295436780
Payments from drug & device makers
Across 54 payments — averaging $24.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$151
- AbbVie$127
- Sun Pharmaceutical Industries Inc.$115
- Novartis$103
- Progenics Pharmaceuticals, Inc.$73
- Olympus America Inc.$67
- plus $689 from 24 others
What the payments were for
- Food & beverage$1,325100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 6 | $151 |
| AbbVie | 6 | $127 |
| Sun Pharmaceutical Industries Inc. | 5 | $115 |
| Novartis | 4 | $103 |
| Progenics Pharmaceuticals, Inc. | 3 | $73 |
| Olympus America Inc. | 3 | $67 |
| SRS Medical Systems, Inc. | 1 | $52 |
| Dendreon Pharmaceuticals LLC | 2 | $44 |
| Seqirus USA Inc | 2 | $43 |
| Novo Nordisk | 2 | $43 |
| Urogen Pharma, Inc. | 1 | $42 |
| Procept Biorobotics Corporation | 1 | $35 |
| Verity Pharmaceuticals Inc. | 1 | $35 |
| Merck | 1 | $33 |
| Exact Sciences | 1 | $29 |
| Immunitybio, Inc. | 1 | $28 |
| Pfizer | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Boston Scientific | 1 | $26 |
| Johnson & Johnson | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Laborie Medical Technologies Corp. | 1 | $22 |
| Tolmar, Inc. | 1 | $20 |
| Coloplast | 1 | $19 |
| ABC Home Medical Supply, Inc. | 1 | $19 |
| AstraZeneca | 1 | $16 |
| Amgen | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
How this compares
$1,325 in reported general payments places this provider in the 75th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 22 | $16,883 |
| MyrbetriqMirabegron | 17 | $12,159 |
| Tamsulosin Hcl | 413 | $5,535 |
| Trospium Chloride ErTrospium Chloride | 17 | $4,078 |
| Finasteride | 216 | $2,720 |
| Trospium Chloride | 25 | $2,050 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 50 | $1,063 |
| Methenamine Hippurate | 13 | $966 |
| Solifenacin Succinate | 17 | $917 |
| Bethanechol Chloride | 14 | $846 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 28 | $520 |
| Oxybutynin Chloride | 25 | $471 |
| Oxybutynin Chloride ErOxybutynin Chloride | 25 | $356 |
| Cephalexin | 15 | $139 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $22 | $16,88322 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,941 family providers in Illinois.
Other family in Park Ridge
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
- Amy BrownellElk Grove Village$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.